SRX Global Inc. SRXH

Q: What is the current share price of SRX Global Inc. (SRXH)?

As of 2026-08-05 17:25 PDT, SRX Global Inc. (SRXH) trades at $1.39 on NYSE American. Its 52-week range is $1.32 to $34.11.

Q: What is the market capitalisation of SRXH?

SRX Global Inc. (SRXH) has a market capitalisation of $27.13M on NYSE American.

Q: What is the P/E ratio of SRXH?

SRXH trades at a trailing price-to-earnings (P/E) ratio of -0.13. The industry average P/E is 22.11. Its price-to-book (P/B) ratio is 0.44.

Q: Is SRXH a good stock to buy?

This page provides a data-driven analysis of SRX Global Inc. (SRXH), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Consumer Defensive · Packaged Foods · United States

https://www.srxglobalinc.com

Company Profile ↓

$1.39

-93.77% 1Y

Mkt Cap$27.13M

P/E-0.13

P/B0.44

52W High$34.11

52W Low$1.32

Book Value$3.29

EPS (TTM)$-10.48

Company Overview

SRX Global Inc. operates an AI-driven platform focused on generating long-term shareholder value through investments in high-conviction operating companies, strategic assets, and technology-enabled opportunities. It leverages proprietary technology, data analytics, and disciplined capital allocation to identify and manage investments across various sectors. The company is based in Tampa, Florida.

Recent Developments

Sep 2025 Revenue of $6.53M (-81.3% YoY); net profit $-45.01M.
Trailing 12 Months Year-on-year growth — revenue -81.3%.
5-Year Trend Long-term compounding — revenue CAGR -32.3%.

Growth & Price Performance

Compounded Sales Growth

5 Years:	-32.32%
1 Year:	-81.32%

Stock Price Performance

1 Year:	-93.77%
6 Months:	-83.73%
3 Months:	-79.34%
1 Month:	+5.57%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bearish

52-Week Range 0% of range

$1.32 $34.11

Trend Signals

Price vs 50-DMABelow
Price vs 200-DMABelow
RSI (14)30.51 · Neutral

Price Performance

1M+5.57%

3M-79.34%

6M-83.73%

1Y-93.77%

Auto-generated from price history and fundamentals; not investment advice.

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Period: Metric:

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

No notable strengths flagged.

CONS

Revenue declined at -32.3% CAGR over 5 years.
Trading 95.9% below its 52-week high.
In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

Valuation

Stock P/E

-0.13

Industry PE

22.11

Forward P/E

PEG Ratio

Book Value

$3.29

Price to Book

0.44

P/S

4.30

EV/EBITDA

Dividend Yield

0.00%

Growth (CAGR)

Revenue 5Y

-32.32%

Profit 5Y

Revenue (YoY)

-81.32%

Earnings (YoY)

Profitability & Returns

ROCE

ROE

ROA

Profit Margin

0.00%

Op Margin

0.00%

Gross Margin

0.00%

EPS (Latest Qtr)

$-1.20

EPS (TTM)

$-10.48

Balance Sheet & Liquidity

Debt/Equity

10.99

Quick Ratio

0.00

Current Ratio

0.00

Debt

$4.47M

Total Assets

$43.36M

Current Assets

$43.15M

Working Capital

$4.58M

Ownership

Promoter Holding

1.97%

Chg in Prom Hold

FII / Inst Holding

0.73%

Chg in FII Hold

Financial Snapshot

Enterprise Value

$27.13M

Total Revenue (TTM)

$6.53M

EBITDA

$-7.98M

Free Cash Flow

$-10.22M

Operating Cash Flow

Shares Outstanding

19.52M

Gross Margin

0.00%

Payout Ratio

0.00%

Peer comparison

Peer companies in the same sector (Consumer Defensive).

#	Name	CMP $	P/E	Mkt Cap	Div Yld %	ROCE %	ROE %	Rev CAGR 5Y %	Profit CAGR 5Y %
1	SRXH SRX Global Inc.	1.39	-0.13	$27.13M	0.00%	-	-	-32.32%	-
2	CCEP Coca-Cola Europacific Partners PLC NDX	108.58	22.11	$48.01B	2.23%	12.76%	22.89%	6.46%	8.80%
3	UNFI United Natural Foods, Inc. R2K	50.83	-77.02	$3.08B	0.00%	-0.62%	-2.30%	14.88%	-
4	WMK Weis Markets, Inc. R2K	74.66	18.43	$1.85B	1.77%	6.79%	7.21%	4.63%	2.70%
5	TPB Turning Point Brands, Inc. R2K	83.71	28.67	$1.62B	0.43%	13.84%	22.52%	7.91%	8.78%
6	WEST Westrock Coffee Company R2K	8.19	-11.07	$799.00M	0.00%	-4.55%	-23.98%	21.21%	-
7	CVGW Calavo Growers Inc R2K	26.09	28.99	$466.33M	0.03%	11.07%	7.97%	-5.55%	138.93%
8	ACU Acme United Corporation R2K	56.86	24.51	$216.66M	1.41%	9.91%	8.46%	0.44%	49.72%
9	YSG Yatsen Holding Limited	3.20	-15.24	$204.09M	0.00%	-5.75%	-4.94%	5.06%	30.03%

Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric	Feb 2015	May 2015	Nov 2015	Feb 2016	May 2016	Nov 2016	Feb 2017	May 2017	Nov 2017	Feb 2018	Mar 2018	May 2018	Jun 2018	Sep 2018	Nov 2018	Feb 2019	Mar 2019	Jun 2019	Sep 2019	Mar 2020	Jun 2020	Sep 2020	Mar 2021	Jun 2021	Sep 2021	Mar 2022	Jun 2022	Sep 2022	Mar 2023	Jun 2023	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	3.82M	3.98M	-	-	3.55M	4.08M	3.93M	12.23M	9.94M	11.13M	10.83M	10.99M	13.20M	17.01M	16.52M	11.87M	9.24M	10.54M	13.12M	7.90M	42.67M	11.37M	0	7.16M	-	-34.55M	2.81M	3.44M
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	4.78M	-	-25.78M	1.75M	2.16M
Gross Profit	-	-	-	-	-	-	-	576	187	77	-	0	2.43M	1.52M	0	0	1.89M	1.66M	836.00K	4.16M	4.12M	4.46M	4.28M	3.90M	4.44M	4.71M	4.73M	4.17M	3.24M	3.59M	4.44M	2.61M	9.42M	4.52M	0	2.38M	-	-8.77M	1.05M	1.27M
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	3.47M	-	-26.85M	4.84M	3.09M
Operating Income	-11.00K	-5.82K	-16.43K	-7.48K	-283.18K	-83.93K	-221.45K	-114.98K	-85.06K	-66.40K	-	-239.51K	-702.00K	-1.41M	-147.52K	-388.90K	-2.71M	-11.26M	-9.68M	-8.53M	-12.50M	-3.28M	-5.14M	-3.20M	-3.97M	-3.96M	-4.26M	-6.40M	-3.25M	-2.58M	-2.62M	-2.47M	-1.32M	-1.13M	0	-1.09M	-	18.08M	-3.79M	-1.82M
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	920.00K	-1.06M	-	21.48M	-7.31M	-4.60M
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	1.29M	1.78M
Pretax Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-962.00K	-	21.74M	-8.61M	-6.38M
Tax Provision	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	2.00K	-	630.00K	4.00K	2.00K
Net Income	-18.75K	-11.91K	-18.69K	-7.49K	-464.48K	-200.56K	-755.15K	-465.67K	-110.70K	-951.49K	-1.66M	-18.02M	-745.00K	-1.44M	502.22K	-166.06K	-2.78M	-161.51M	-6.03M	-9.45M	-18.40M	-1.69M	-12.85M	24.78M	-3.46M	-4.04M	-4.37M	-6.55M	-3.48M	-2.96M	-1.62M	-2.83M	-3.12M	1.53M	-3.98M	-964.00K	-	-15.26M	-8.61M	-6.38M
Diluted EPS	0.00	0.00	0.00	0.00	-0.00	0.00	-0.01	-0.01	0.00	-0.31	-	-	-	-	0.00	-0.09	-	-	-	-	-2.26	-0.21	-1.38	1.19	-0.12	-0.14	-0.15	-0.22	-5.03	-4.27	-2.30	-3.60	-0.14	0.73	-0.28	-0.07	-44.40	-	-0.09	-1.20
R&D Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Profit & Loss (Annual)

Figures in USD.

Metric	Aug 2001	Aug 2002	Aug 2003	Aug 2004	Aug 2005	Aug 2006	Aug 2007	Aug 2008	Aug 2009	Aug 2010	Aug 2011	Aug 2012	Aug 2013	Aug 2014	Aug 2015	Aug 2016	Aug 2017	Aug 2018	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Sep 2024	Dec 2024	Sep 2025
Revenue	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	48	1.73K	475	14.79M	15.58M	42.59M	46.01M	54.66M	38.59M	0	34.98M	6.53M
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	5.01M
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.40K	264	7.30M	5.86M	16.11M	15.37M	15.26M	11.80M	0	12.99M	1.53M
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	12.93M
Operating Income	-	-	-	-	-	-	-	-	-	-	-39.23K	-13.22K	-22.08K	-27.27K	-24.65K	-459.68K	-524.04K	-527.89K	-5.16M	-36.33M	-27.32M	-17.28M	-38.78M	-21.18M	0	-5.97M	-11.41M
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4.39M	-	-7.98M
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	628.00K
Pretax Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-8.64M
Tax Provision	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0
Net Income	-16.20K	-125.00K	0	0	0	0	0	0	0	-38.42K	-40.85K	-15.91K	-94.17K	-51.24K	-49.67K	-933.76K	-1.74M	-2.95M	-6.03M	-184.46M	-59.34M	3.39M	-39.32M	-22.77M	-43.05M	-168.00K	-45.01M
Diluted EPS	-	-	-	-	-	-	-	-	-	-	-0.68	-0.26	-1.56	0.00	0.00	-0.01	-0.02	-	-	-	-7.26	0.14	-58.93	-32.29	-3.01	-0.10	-1.81
R&D Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	100.00K	500.00K	500.00K	100.00K	-	100.00K	-

Balance Sheet (Annual)

Figures in USD.

Metric	Jan 2001	Aug 2009	Aug 2010	Aug 2011	Aug 2012	Aug 2013	Aug 2014	Aug 2015	Aug 2016	Aug 2017	Dec 2017	Aug 2018	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Sep 2023	Dec 2023	Sep 2024	Dec 2024	Sep 2025
Total Assets	-	-	-	16.99K	12.80K	8.57K	4.38K	2.19K	16.64K	16.32K	-	209.08K	5.99M	53.53M	51.25M	74.66M	38.68M	-	16.74M	33.76M	15.80M	8.40M
Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	13.64M	-	8.13M
Cash & Equivalents	0	-	59	37	38	0	0	0	10.20K	1.44K	-	199.67K	3.95M	2.36M	3.93M	21.73M	3.17M	-	4.46M	106.00K	3.07M	1.31M
Inventory	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3.37M	-	2.08M
Receivables	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	9.28M	-	3.94M
Total Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	9.03M	50.04M	79.36M	16.79M	17.15M	-	13.76M	88.88M	7.15M	8.00M
Current Liabilities	-	-	-	56.94K	68.66K	89.36K	37.40K	59.87K	590.96K	1.20M	-	2.86M	9.03M	33.03M	54.58M	7.34M	5.58M	-	13.69M	81.30M	7.15M	3.54M
Long Term Debt	-	-	-	-	-	-	-	-	-	0	-	0	6.20M	16.37M	24.59M	9.41M	11.44M	-	4.62M	696.00K	2.41M	4.45M
Total Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	45.31M	-	4.47M
Total Equity	-	30.34K	899	-39.95K	-55.86K	-80.79K	-33.02K	-2.40M	-574.32K	-1.18M	-2.12M	-2.65M	-3.04M	-7.07M	-28.10M	57.88M	21.53M	-33.78M	2.98M	-55.12M	8.65M	407.00K
Shares Outstanding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	14.30M	-	24.92M

Cash Flows (Annual)

Figures in USD.

Metric	Aug 2011	Aug 2012	Aug 2013	Aug 2014	Aug 2015	Aug 2016	Aug 2017	Aug 2018	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Sep 2024	Dec 2024	Sep 2025
Operating Cash Flow	-18.38K	-17.74K	-17.19K	-22.62K	-22.88K	-180.60K	-39.76K	-	-6.90M	-20.97M	-7.50M	-11.86M	-20.55M	97.00K	-1.48M	-4.36M	-8.14M
Investing Cash Flow	0	0	0	0	0	-250.00K	0	0	-31.00K	-20.21M	-151.00K	-353.00K	-198.00K	-18.00K	-1.09M	-2.25M	5.91M
Financing Cash Flow	18.36K	17.74K	17.15K	22.62K	22.88K	440.80K	31.00K	-	10.72M	39.76M	9.11M	37.16M	1.28M	-5.10M	932.00K	5.22M	12.17M
Capital Expenditure	-	-	-	-	-	-	-	-	-31.00K	-110.00K	-151.00K	-353.00K	-198.00K	-18.00K	-	-41.00K	-2.08M
Free Cash Flow	-	-	-	-	-	-	-	-	-6.93M	-21.08M	-7.66M	-12.21M	-20.75M	79.00K	-1.48M	-4.40M	-10.22M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1.64M	-	1.41M
Share Buybacks	-	-	-	-	-	-	-	-	-	-	0	1.60M	0	-	-	-	-

Ratios (Annual)

Figures in %.

Metric	Aug 2001	Aug 2002	Aug 2003	Aug 2004	Aug 2005	Aug 2006	Aug 2007	Aug 2008	Aug 2009	Aug 2010	Aug 2011	Aug 2012	Aug 2013	Aug 2014	Aug 2015	Aug 2016	Aug 2017	Aug 2018	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Sep 2024	Dec 2024	Sep 2025
Gross Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	80.7%	55.6%	49.3%	37.6%	37.8%	33.4%	27.9%	30.6%	-	37.1%	23.4%
Operating Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-957,670.8%	-30,221.3%	-111,134.1%	-34.9%	-233.2%	-64.2%	-37.6%	-71.0%	-54.9%	-	-17.1%	-174.6%
Net Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1,945,335.4%	-100,533.9%	-621,225.1%	-40.8%	-1,184.2%	-139.3%	7.4%	-71.9%	-59.0%	-	-0.5%	-688.8%
ROE %	-	-	-	-	-	-	-	-	0.0%	-4,273.7%	102.3%	28.5%	116.6%	155.2%	2.1%	162.6%	147.4%	111.4%	198.1%	2,608.7%	211.1%	5.9%	-182.6%	-764.6%	78.1%	-1.9%	-11,058.0%
ROCE %	-	-	-	-	-	-	-	-	-	-	98.2%	23.7%	27.3%	82.6%	42.7%	80.0%	44.3%	19.9%	169.6%	-177.1%	822.2%	-25.7%	-117.2%	-695.5%	-0.0%	-69.0%	-234.7%

Shareholding Pattern

Insiders

1.97%

Institutions

0.73%

Public Float

0.74%

Top Institutional Holders

#	Holder	% Held	Shares	Value
1	SBI Securities Co., Ltd.	0.01%	56.58K	$81.48K
2	Jane Street Group, LLC	-	9.92K	$14.29K
3	Geode Capital Management, LLC	-	4.12K	$5.94K
4	Two Sigma Securities, LLC	-	3.25K	$4.68K
5	Scotia Capital Inc.	-	1.80K	$2.59K
6	UBS Group AG	-	1.43K	$2.06K
7	Xtx Topco Ltd	-	1.22K	$1.76K
8	Morgan Stanley	-	567	$816
9	Magnus Financial Group LLC	-	842	$1.21K
10	Bogart Wealth, LLC	-	10.00K	$14.40K

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for SRXH

Google News Wed, 05 Aug 2026

symbol__ Stock Quote Price and Forecast - CNN

<a href="https://news.google.com/rss/articles/CBMiUEFVX3lxTFBPR1h5aXFYQ0VtWGo1cFZGQi16ZlRjRU5WSGxUaTUzUE9uVGIzUnJUdFdfU2kteDNzdzZMYnRNaVF4dlJCSHgyVkJBXzdMWGRu?oc=5" target="_blank">symbol__ Stock Quote Price and Forecast</a>  <fon…

Google News Fri, 31 Jul 2026

SRXH Stock Climbed 15% Today — What’s Driving The Rally? - Stocktwits

<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxQdC1JVEtqN0hVVlptYzJlREJsMUVNRVJPUjM1QUJTWUhiaWJUNVhYLTluQy1GRWg0c1hjakh3czgtMGJtdzZwQUtsLVVxczVIT084WWlPZ1ZxS2NVUTBnaWdCa1VkWTcxSkxSRjFJWHZ2eFdkMFhOeEVZQUdzWkVxelliQVJCQnRZTmFzdE…

Google News Mon, 03 Aug 2026

Smartkem and Ferrox merger would strengthen critical minerals sourcing - Stock Titan

<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxQazgxaXJRTF92TTIzRXByaFRsWlZ3bHlPVGViUEk2Tkxfc1UwVGpfRkdzNGhLMEpYNnMtZ3FqOE0wRU5mcFVvWGhaZHdpSzZ3UVExNFowR3BUWnhubGplNnhsdnJYOXNxcnRkYW1qUnpaNlczcjBWalJpX1lpVHlRQWxmNGlMQ2NJek1LNj…

Google News ue, 04 Aug 2026

SRX Global Acquires Stake in Vistagen Therapeutics - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxPWGhPX3puWXZxTjMwUTIzUzVUbjYzakJld1ZwdVAyUWlyRjZjYU1mZzJKbDg0SjZjUVBscmxIYXJEOUZPZTcxbXlxZm1iRlEySGtZZDFlNGl2ZlZLWU1FNW5mYzZLNHFuVE1kdUJKd01aZTE0RUNXNG5oN2tlcFR3eUpPeXBHdThhYmhUYk…

Google News Wed, 05 Aug 2026

SRX Global (NYSE American: SRXH) Acquires Stake in Vistagen Therapeutics - theglobeandmail.com

<a href="https://news.google.com/rss/articles/CBMi7AFBVV95cUxNN2E1eUFwTWxWNUJWVkIzcnRhVGFDMUVuQzRVXzE1SFd4NHNmOEpTaWRiNWNxUVQwRy1vZXMzMWIzdWRseXBEQ1FYZGc2TkVhMXZWek1yNk9LUTFBYU9QV1dHS1NnMzhocDFYT3I2Q2l5WF9qR2hsTjJyLTNUT2pIMm5rdU1RalhpTzJpTX…

Google News Wed, 05 Aug 2026

Top Amass Brands (AMSS) Competitors 2026 - MarketBeat

<a href="https://news.google.com/rss/articles/CBMigAFBVV95cUxPTm8zUXB5SldHTFNnXzREU3kyV0RGdVotZWRLSUNQSFRuWlpvMjA3X181N0k4WFQzNmlVMmZOS0VTdTdnNXRJb2c3VnF2Mm81N0pGZkQtdkw3NF9Bdlc0dy1PU1IxdEVuTjlDby01cmFSZDc2dnJMN1lLZmNNbnFpNA?oc=5" target="_…

SRXH — Frequently Asked Questions

What is the current share price of SRX Global Inc. (SRXH)?

As of 2026-08-05 17:25 PDT, SRX Global Inc. (SRXH) trades at $1.39 on NYSE American. Its 52-week range is $1.32 to $34.11.

What is the market capitalisation of SRXH?

SRX Global Inc. (SRXH) has a market capitalisation of $27.13M on NYSE American.

What is the P/E ratio of SRXH?

SRXH trades at a trailing price-to-earnings (P/E) ratio of -0.13. The industry average P/E is 22.11. Its price-to-book (P/B) ratio is 0.44.

Is SRXH a good stock to buy?

This page provides a data-driven analysis of SRX Global Inc. (SRXH), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Consumer Defensive Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks

SRX Global Inc. SRXH

Company Overview

Recent Developments

Growth & Price Performance

Compounded Sales Growth

Stock Price Performance

Price Chart

Technical Trend

Fundamental Growth Charts

PROS

CONS

Valuation

Growth (CAGR)

Profitability & Returns

Balance Sheet & Liquidity

Ownership

Financial Snapshot

Peer comparison

Quarterly Results

Profit & Loss (Annual)

Balance Sheet (Annual)

Cash Flows (Annual)

Ratios (Annual)

Shareholding Pattern

Top Institutional Holders

Analyst View

Latest News

symbol__ Stock Quote Price and Forecast - CNN

SRXH Stock Climbed 15% Today — What’s Driving The Rally? - Stocktwits

Smartkem and Ferrox merger would strengthen critical minerals sourcing - Stock Titan

SRX Global Acquires Stake in Vistagen Therapeutics - Yahoo Finance

SRX Global (NYSE American: SRXH) Acquires Stake in Vistagen Therapeutics - theglobeandmail.com

Top Amass Brands (AMSS) Competitors 2026 - MarketBeat

SRXH — Frequently Asked Questions

What is the current share price of SRX Global Inc. (SRXH)?

What is the market capitalisation of SRXH?

What is the P/E ratio of SRXH?

Is SRXH a good stock to buy?

Explore More